选择性葡萄糖皮质体受体连接体的基因调节效应
bioRxiv : the preprint server for biology
|July 16, 2025
概括
合成葡萄皮质激素 (GCs) 是抗炎药物,但会引起副作用. 这项研究发现,经过测试的GC配体并没有选择性地向特定的分子反应,尽管有效性各不相同.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 合成葡萄糖皮质体 (GCs) 是广泛使用的针对葡萄糖皮质体受体 (GR) 的抗炎药物.
- 它们广泛的免疫抑制作用受到显著不良副作用的限制.
- 开发具有减少副作用的选择性GR配体是主要的治疗目标.
研究的目的:
- 调查合成GC是否可以选择性地准特定的分子反应.
- 为了比较由十种不同的连接体诱导的基因表达和调节元素活性变化.
- 评估开发更安全,选择性的GR配体的潜力.
主要方法:
- 使用mRNA-seq. 的基因表达的全基因组分析.
- 使用STARR-seq.进行基因调节元件活性全基因组评估.
- 对十种合成GC配体进行了比较分析,其副作用概况各不相同.
主要成果:
- 联结体效应与非选择性GR激动剂德甲的反应有很强的相关性.
- 仅靠连接剂的有效性就解释了93%的调节元件活性变化.
- 有限的证据表明,被测试的配体对特定分子反应的选择性向.
结论:
- 经过测试的GR配体引起的分子反应与其疗效成比例.
- 测试的配体对分子GC反应的不同子集没有显示选择性.
- 目前的合成GC没有提供有针对性的抗炎作用,没有更广泛的分子效应.
更多相关视频
13:22A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System
Published on: September 10, 2013
12.1K
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
12.9K
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Transducer Mechanism: Nuclear Receptors
1.7K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K
GPCR Desensitization
6.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.5K
Global Regulatory Systems
82
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
82
G Protein-coupled Receptors
13.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.5K
Glucagon-like Receptor Agonists
424
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
424
